Uma Lakshmipathy

Thermo Fisher Scientific (United States)

Biochemistry, Genetics and Molecular BiologyEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee”.

Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee

Cytotherapy(2024)10.1016/j.jcyt.2024.05.022

N/A

0DataRank · unranked

46 citations

Uma Lakshmipathy, Xiaokui Zhang, Kapil Bharti, Dominic Wall, Yoji Sato +11 more

Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group

Cytotherapy(2024)10.1016/j.jcyt.2024.05.024

N/A

0DataRank · unranked

10 citations

Jennifer N. Solomon, Fernanda Masri, Amanda A. Mack, Nisha Durand, Emmanuelle Cameau +12 more